CA Patent

CA2877190A1 — Medicament form for release of active ingredients

Assigned to Hennig Arzneimittel GmbH and Co KG · Expires 2014-01-03 · 12y expired

What this patent protects

This invention is concerned with the provision of medicament forms which enable effective administration of a medicament which is usually taken twice or more daily by way of a single daily dose. This is achieved in accordance with the invention by provision of a medicament form c…

USPTO Abstract

This invention is concerned with the provision of medicament forms which enable effective administration of a medicament which is usually taken twice or more daily by way of a single daily dose. This is achieved in accordance with the invention by provision of a medicament form comprising a core, a gastric juice-resistant intermediate layer disposed on the surface of the core, and a shell disposed on the opposite side of the intermediate layer from the core. Both the core and the shell comprise a proportion of an active ingredient. The active ingredient is released in at least biphasic form from the medicament form, the first phase relating to the immediate release of the active ingredient after ingestion into the gastric juice. The present invention additionally relates to a process for producing the medicament form and to uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2877190A1
Jurisdiction
CA
Classification
Expires
2014-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Hennig Arzneimittel GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.